Law360, New York (June 14, 2010, 7:29 PM ET) -- A state court judge on Monday threw out the commonwealth of Pennsylvania's suit alleging that Johnson & Johnson unit Janssen Pharmaceutica Inc. had improperly marketed the antipsychotic drug Risperdal, and an attorney for Pennsylvania vowed to appeal.
Judge Frederica Massiah-Jackson of the Philadelphia Court of Common Pleas granted Janssen's motion for a nonsuit on Monday morning, J&J spokesman Greg Panico told Law360.
"We are pleased with the judge's decision, and the evidence presented by the plaintiffs failed to demonstrate that Janssen had committed any fraud on...
J&J Gets Pa.'s Off-Label Risperdal Suit Tossed
To view the full article, take a free trial now.
